Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-014958)

Filing Details

Accession Number:: 0001209191-17-014958
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-27 19:04:50
Reporting Period:: 2017-02-23

Filing Date:: 2017-02-27
Accepted Time:: 2017-02-27 19:04:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-02-23	1,470,525	$8.65	9,270,195	No	4	S	Indirect	By LVP
Common Stock	Disposition	2017-02-23	29,475	$8.65	185,807	No	4	S	Indirect	By LCA
Common Stock	Disposition	2017-02-27	980,350	$9.05	8,289,845	No	4	S	Indirect	By LVP
Common Stock	Disposition	2017-02-27	19,650	$9.05	166,157	No	4	S	Indirect	By LCA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LCA
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LCA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	204,210	Direct

Footnotes

Reflects shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Mr. Enright is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.